Endocrinology Archives

Videos

An update on semaglutide for CKD in the presence of T2D

In this Product Explainer, Endocrinologist Prof Richard MacIsaac provides an update on the chronic kidney disease (CKD) indication for semaglutide, explains the PBS criteria and how healthcare professionals can initiate this GLP-1 RA.

Podcasts

The role of GLP-1 in the management of CKD in T2D

Dr Charlotte Hespe and Dr Ramy Bishay discuss the latest recommendations for screening and assessing patients for early stage CKD.

Videos

Dapagliflozin PBS update in CKD: Expert overview

In this Product Explainer, Nephrologist Prof Eugenia Pedagogos reviews the new PBS listing for dapagliflozin in chronic kidney disease, discusses clinical data, and frames the clinical implications for CKD management.

Podcasts

Vitamin D deficiency in GP: Optimising patient outcomes

Prof Ebeling AO explains who is truly at risk, when to check levels and how to optimise vitamin D status in everyday general practice.

Videos

Management of a gluten free diet with GluteGuard

In this Product Explainer, Gastroenterologist Prof Finlay Macrae AO explains the common challenges when following a strict gluten free diet and the role of enzyme supplementation with GluteGuard.

Videos

Cardiorenal protection with dapagliflozin: An expert overview

In this Product Explainer, Cardiologist Prof Andrew Sindone explains the role of dapagliflozin in cardiorenal protection in patients with heart failure, chronic kidney disease and/or type 2 diabetes.

Videos

Tirzepatide Product Explainer – A new indication and data

In this Product Explainer, Endocrinologist Dr Ted Wu explains the comparative features of tirzepatide and its indications (6 mins).

Podcasts

Tirzepatide compared to semaglutide for treatment of obesity – Latest evidence

A/Prof Sam Hocking provides an update on this latest study.

Videos

Diabetes Specific Nutritional Formulas (DSNFs) demystified

In this Product Explainer, General Practitioner Dr Gary Deed explains the role of Diabetes Specific Nutritional Formulas (DSNFs) and addresses some myths and misconceptions (6 mins).

Clinical Articles

Vale Cres Eastman, the man who saved a million brains

Professor Eastman was a passionate advocate for women and children in Australia and the developing world alike…

Videos

Reducing cardiovascular death with SGLT2 inhibitors – Important updates for GPs

Prof Sindone and Dr Wu discuss the importance of SGLT2 inhibitors and the ground-breaking evidence that has seen this class of drugs now PBS-listed.

Videos

Clinical Case: 36-year-old female with obesity

In this Quick Case Endocrinologist A/Prof Samantha Hocking presents the obesity management case of a 36-year-old female, describes treatment options, clinical outcomes, and provides some take home messages.

Endocrinology

An update on semaglutide for CKD in the presence of T2D

In this Product Explainer, Endocrinologist Prof Richard MacIsaac provides an update on the chronic kidney disease (CKD) indication for semaglutide, explains the PBS criteria and how healthcare professionals can initiate this GLP-1 RA.

The role of GLP-1 in the management of CKD in T2D

Dr Charlotte Hespe and Dr Ramy Bishay discuss the latest recommendations for screening and assessing patients for early stage CKD.

Dapagliflozin PBS update in CKD: Expert overview

In this Product Explainer, Nephrologist Prof Eugenia Pedagogos reviews the new PBS listing for dapagliflozin in chronic kidney disease, discusses clinical data, and frames the clinical implications for CKD management.

Vitamin D deficiency in GP: Optimising patient outcomes

Prof Ebeling AO explains who is truly at risk, when to check levels and how to optimise vitamin D status in everyday general practice.

Management of a gluten free diet with GluteGuard

In this Product Explainer, Gastroenterologist Prof Finlay Macrae AO explains the common challenges when following a strict gluten free diet and the role of enzyme supplementation with GluteGuard.

Cardiorenal protection with dapagliflozin: An expert overview

In this Product Explainer, Cardiologist Prof Andrew Sindone explains the role of dapagliflozin in cardiorenal protection in patients with heart failure, chronic kidney disease and/or type 2 diabetes.

Tirzepatide Product Explainer – A new indication and data

In this Product Explainer, Endocrinologist Dr Ted Wu explains the comparative features of tirzepatide and its indications (6 mins).

Tirzepatide compared to semaglutide for treatment of obesity – Latest evidence

A/Prof Sam Hocking provides an update on this latest study.

Diabetes Specific Nutritional Formulas (DSNFs) demystified

In this Product Explainer, General Practitioner Dr Gary Deed explains the role of Diabetes Specific Nutritional Formulas (DSNFs) and addresses some myths and misconceptions (6 mins).

Vale Cres Eastman, the man who saved a million brains

Professor Eastman was a passionate advocate for women and children in Australia and the developing world alike…

Reducing cardiovascular death with SGLT2 inhibitors – Important updates for GPs

Prof Sindone and Dr Wu discuss the importance of SGLT2 inhibitors and the ground-breaking evidence that has seen this class of drugs now PBS-listed.

Clinical Case: 36-year-old female with obesity

In this Quick Case Endocrinologist A/Prof Samantha Hocking presents the obesity management case of a 36-year-old female, describes treatment options, clinical outcomes, and provides some take home messages.

Get the app

Site

Company

Connect

Legal

Healthed

Upcoming Healthed Webcast

Abnormal Liver Function Test Interpretation

Tuesday 31st March, 7pm - 9pm AEDT

Speaker

Dr Emily Nash

Gastroenterologist and Hepatologist; Chris O'Brien Lifehouse; Clinical Associate Lecturer, University of Sydney

Join Dr Emily Nash for their lecture where they will offer a framework to interpret abnormal LFTS and suggest diagnostic algorithms to help determine the most appropriate next step.

Endocrinology

In this Product Explainer, Endocrinologist Prof Richard MacIsaac provides an update on the chronic kidney disease (CKD) indication for semaglutide, explains the PBS criteria and how healthcare professionals can initiate this GLP-1 RA.

Dr Charlotte Hespe and Dr Ramy Bishay discuss the latest recommendations for screening and assessing patients for early stage CKD.

In this Product Explainer, Nephrologist Prof Eugenia Pedagogos reviews the new PBS listing for dapagliflozin in chronic kidney disease, discusses clinical data, and frames the clinical implications for CKD management.

Prof Ebeling AO explains who is truly at risk, when to check levels and how to optimise vitamin D status in everyday general practice.

In this Product Explainer, Gastroenterologist Prof Finlay Macrae AO explains the common challenges when following a strict gluten free diet and the role of enzyme supplementation with GluteGuard.

In this Product Explainer, Cardiologist Prof Andrew Sindone explains the role of dapagliflozin in cardiorenal protection in patients with heart failure, chronic kidney disease and/or type 2 diabetes.

In this Product Explainer, Endocrinologist Dr Ted Wu explains the comparative features of tirzepatide and its indications (6 mins).

A/Prof Sam Hocking provides an update on this latest study.

In this Product Explainer, General Practitioner Dr Gary Deed explains the role of Diabetes Specific Nutritional Formulas (DSNFs) and addresses some myths and misconceptions (6 mins).

Professor Eastman was a passionate advocate for women and children in Australia and the developing world alike…

Prof Sindone and Dr Wu discuss the importance of SGLT2 inhibitors and the ground-breaking evidence that has seen this class of drugs now PBS-listed.

In this Quick Case Endocrinologist A/Prof Samantha Hocking presents the obesity management case of a 36-year-old female, describes treatment options, clinical outcomes, and provides some take home messages.

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Extra Details

Healthed

Upcoming Healthed Webcast

Abnormal Liver Function Test Interpretation

Tuesday 31st March, 7pm - 9pm AEDT

Speaker

Dr Emily Nash

Gastroenterologist and Hepatologist; Chris O'Brien Lifehouse; Clinical Associate Lecturer, University of Sydney

Join Dr Emily Nash for their lecture where they will offer a framework to interpret abnormal LFTS and suggest diagnostic algorithms to help determine the most appropriate next step.